The Private Markets Update highlights key developments emerging from private markets across Europe, the UK and the United States, exploring the cross-border issues that matter to investors and sponsors in alternative assets. ...more
10/16/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Markets ,
Cross-Border ,
EU ,
EUMR ,
Financial Conduct Authority (FCA) ,
Greenwashing ,
Healthcare ,
Investment ,
Investment Management ,
Investors ,
Life Sciences ,
Mergers ,
Private Equity ,
Regulatory Agenda ,
Regulatory Requirements ,
UK ,
United States
The EU Artificial Intelligence Act (or “AI Act”) is the world’s first legislation to regulate the use of AI. It leaves room for “technical soft law”; but, inevitably (being the first and being broad in scope), it will set...more
7/31/2023
/ Artificial Intelligence ,
China ,
Code of Conduct ,
Data Privacy ,
Data Security ,
Ethics ,
EU ,
New Legislation ,
Popular ,
Regulatory Agenda ,
Risk Management ,
Transparency ,
UK
In light of the increasing number of enforcement incidents under the General Data Protection Regulation (GDPR), organisations active in the Health and Life Sciences sectors in the United Kingdom, the European Union (EU) and...more
3/3/2023
/ Data Collection ,
Data Protection ,
Data-Sharing ,
EU ,
European Economic Area (EEA) ,
General Data Protection Regulation (GDPR) ,
Health Information Technologies ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Life Sciences ,
Personal Information ,
Regulatory Agenda ,
UK